BIOMAT Database Logo BIOMAT Database Logo

Human T-cell leukemia virus-1-positive cell line established from a patient with small cell lung cancer. 1992

H Matsuzaki, and H Hata, and N Asou, and M Yoshida, and F Matsuno, and M Takeya, and K Yamaguchi, and I Sanada, and K Takatsuki
Second Department of Internal Medicine, Kumamoto University Medical School.

A stable cell line, KHM-3S, was established from a patient with small cell lung cancer (SCLC), who had a high serum level of soluble interleukin 2 receptors (sIL2-R) and was seropositive for human T cell leukemia virus (HTLV)-1. KHM-3S cells were positive for IL2-R (Tac) and NKH-1, but negative for other lymphocytic markers such as OKT 11, OKT 4, OKT 8, T cell receptor (WT 31), B 1, and B 4. Moreover, the KHM-3S cells were negative for leukocyte common antigen and strongly positive for neuron-specific enolase (NSE). Secretion of sIL2-R and NSE by the KHM-3S line was detected by an enzyme-linked immunosorbent assay. Rearrangement of the T cell receptor gene and monoclonal HTLV-1 integration were found by Southern blot analysis of KHM-3S DNA. However, Northern blot analysis showed no T cell receptor mRNA. KHM-3S may be useful for studies on the role of HTLV-1 in carcinogenesis and IL2-R expression in SCLC.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000954 Antigens, Surface Antigens on surfaces of cells, including infectious or foreign cells or viruses. They are usually protein-containing groups on cell membranes or walls and may be isolated. Cell Surface Antigens,Surface Antigens,Surface Markers, Immunological,Cell Surface Antigen,Immunologic Surface Markers,Markers, Immunological Surface,Surface Antigen,Surface Markers, Immunologic,Antigen, Cell Surface,Antigen, Surface,Antigens, Cell Surface,Immunological Surface Markers,Markers, Immunologic Surface,Surface Antigen, Cell,Surface Antigens, Cell
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D015139 Blotting, Southern A method (first developed by E.M. Southern) for detection of DNA that has been electrophoretically separated and immobilized by blotting on nitrocellulose or other type of paper or nylon membrane followed by hybridization with labeled NUCLEIC ACID PROBES. Southern Blotting,Blot, Southern,Southern Blot
D015152 Blotting, Northern Detection of RNA that has been electrophoretically separated and immobilized by blotting on nitrocellulose or other type of paper or nylon membrane followed by hybridization with labeled NUCLEIC ACID PROBES. Northern Blotting,Blot, Northern,Northern Blot,Blots, Northern,Blottings, Northern,Northern Blots,Northern Blottings
D015368 Human T-lymphotropic virus 1 A strain of PRIMATE T-LYMPHOTROPIC VIRUS 1 isolated from mature T4 cells in patients with T-lymphoproliferation malignancies. It causes adult T-cell leukemia (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), T-cell lymphoma (LYMPHOMA, T-CELL), and is involved in mycosis fungoides, SEZARY SYNDROME and tropical spastic paraparesis (PARAPARESIS, TROPICAL SPASTIC). ATLV,Adult T-Cell Leukemia-Lymphoma Virus I,HTLV-1,HTLV-I,Human T-Cell Leukemia Virus I,Leukemia Virus I, Human T-Cell,T-Cell Leukemia Virus I, Human,Adult T Cell Leukemia Lymphoma Virus I,Human T Cell Leukemia Virus I,Leukemia Lymphoma Virus I, Adult T Cell,Leukemia Virus I, Human T Cell,T Cell Leukemia Virus I, Human,Human T lymphotropic virus 1

Related Publications

H Matsuzaki, and H Hata, and N Asou, and M Yoshida, and F Matsuno, and M Takeya, and K Yamaguchi, and I Sanada, and K Takatsuki
Interleukin 2 acts directly on a Tac-positive cloned B cell line established from a patient with adult T cell leukemia.
October 1985, Journal of immunology (Baltimore, Md. : 1950),
H Matsuzaki, and H Hata, and N Asou, and M Yoshida, and F Matsuno, and M Takeya, and K Yamaguchi, and I Sanada, and K Takatsuki
Human T-cell lymphotropic virus-1-positive T-cell leukemia/lymphoma.
July 1998, Archives of pathology & laboratory medicine,
H Matsuzaki, and H Hata, and N Asou, and M Yoshida, and F Matsuno, and M Takeya, and K Yamaguchi, and I Sanada, and K Takatsuki
A novel CD10-positive erythroid cell line, RM10, established from a patient with chronic myelogenous leukemia.
May 1990, Leukemia,
H Matsuzaki, and H Hata, and N Asou, and M Yoshida, and F Matsuno, and M Takeya, and K Yamaguchi, and I Sanada, and K Takatsuki
CD4- and CD56-positive T-cell line, MTA, established from natural killer-like T-cell leukemia/lymphoma.
April 1999, International journal of hematology,
H Matsuzaki, and H Hata, and N Asou, and M Yoshida, and F Matsuno, and M Takeya, and K Yamaguchi, and I Sanada, and K Takatsuki
A Ki-1-positive cell line expressing Epstein-Barr virus antigens, established from a child with Ki-1-positive lymphoma.
January 1993, Intervirology,
H Matsuzaki, and H Hata, and N Asou, and M Yoshida, and F Matsuno, and M Takeya, and K Yamaguchi, and I Sanada, and K Takatsuki
Human T-cell leukemia virus type 1-positive lymphomatoid papulosis.
April 2016, European journal of dermatology : EJD,
H Matsuzaki, and H Hata, and N Asou, and M Yoshida, and F Matsuno, and M Takeya, and K Yamaguchi, and I Sanada, and K Takatsuki
A clonal CD4-positive T-cell line established from the blood of a patient with Sézary syndrome.
January 1991, The Journal of investigative dermatology,
H Matsuzaki, and H Hata, and N Asou, and M Yoshida, and F Matsuno, and M Takeya, and K Yamaguchi, and I Sanada, and K Takatsuki
Productive nonlytic human immunodeficiency virus type 1 replication in a newly established human leukemia cell line.
November 1992, Proceedings of the National Academy of Sciences of the United States of America,
H Matsuzaki, and H Hata, and N Asou, and M Yoshida, and F Matsuno, and M Takeya, and K Yamaguchi, and I Sanada, and K Takatsuki
A novel Ph1 chromosome positive cell line established from a patient with chronic myelogenous leukemia in blastic crisis.
January 1985, Leukemia research,
H Matsuzaki, and H Hata, and N Asou, and M Yoshida, and F Matsuno, and M Takeya, and K Yamaguchi, and I Sanada, and K Takatsuki
CD80 expression in an HLA-A2-positive human non-small cell lung cancer cell line enhances tumor-specific cytotoxicity of HLA-A2-positive T cells derived from a normal donor and a patient with non-small cell lung cancer.
December 1998, International journal of cancer,
Copied contents to your clipboard!